180 Fenglin Road
180 Fenglin Road
Shanghai, China3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-08-24 | NCT05987826 | |
| Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery | Critical Illness, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Not yet recruiting | Not stated | 2026-04-13 | NCT07521787 | |
| Carotid Atherosclerosis in Predicting Coronary Artery Disease | Arterial Occlusive Diseases, Carotid Atherosclerosis, Coronary Arteriosclerosis, arteriosclerosis disorder, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, nervous system disorder, vascular disorder | Recruiting | Not stated | 2024-02-12 | NCT06253962 |